IDO1 and IDO2 are members of tryptophan catabolic pathways expressed by tumor cells and tumor microenvironment cells (dendritic cells, macrophages, endothelial cells, tumor-associated Fibroblasts). This evidence concerns the gene IDO1 and neoplasm.